Viken, Sweden

Thore E Falkvall

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 37(Granted Patents)


Location History:

  • Viken, SE (1985)
  • Helsingborg, SE (1986)

Company Filing History:


Years Active: 1985-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thore E Falkvall: Innovator in Medical Technology

Introduction

Thore E Falkvall is a notable inventor based in Viken, Sweden. He has made significant contributions to the field of medical technology, particularly in the treatment of blood and similar liquids. With a total of two patents to his name, Falkvall's work has had a meaningful impact on medical practices.

Latest Patents

Falkvall's latest patents include a "Hose set for extracorporeal treatment of blood and similar liquids." This innovative tube set is designed for extracorporeal treatment, such as dialysis, and features a spacer that connects the inlet and outlet ends of a pump segment. The spacer is engineered to facilitate the transfer of liquid and includes ports for withdrawing samples or supplying reagents. Another significant patent is a "Filtering device," which incorporates a pressure-sensitive control valve to manage overflow. This device is particularly useful in medical treatments like hemofiltration and plasmapheresis.

Career Highlights

Thore E Falkvall is associated with Gambro Lundia AB, a company known for its advancements in medical technology. His work at Gambro has allowed him to focus on developing innovative solutions that enhance patient care and treatment efficiency.

Collaborations

Falkvall has collaborated with notable colleagues, including Per-Oloy A Carlsson and Rolf E Karlberg. These partnerships have contributed to the successful development of his patented technologies.

Conclusion

Thore E Falkvall's contributions to medical technology through his patents demonstrate his commitment to improving healthcare solutions. His innovative designs continue to influence the field and enhance treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…